We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Avacta Group plc announced that it has entered into a non-exclusive distribution agreement with Calibre Scientific Inc. for Avacta’s AffiDX SARS-CoV-2 antigen lateral flow test for use in the UK and European Economic Area (EEA).